A potential longer term effect of concern is that higher levels of FGF23 are associated with both cardiovascular events and death in advanced CKD [23] and that FGF23 is associated with left ventricular hypertrophy (LVH) in human studies [24]. This evidence concerns the gene FGF23 and chronic kidney disease.